128 related articles for article (PubMed ID: 22173437)
1. The influence of melatonin and agomelatine on urodynamic parameters in experimental overactive bladder model--preliminary results.
Dobrek Ł; Thor PJ
Postepy Hig Med Dosw (Online); 2011 Nov; 65():725-33. PubMed ID: 22173437
[TBL] [Abstract][Full Text] [Related]
2. [Autonomic nervous system activity estimated by heart rate variability in cyclophosphamide-induced overactive bladder experimental model].
Dobrek Ł; Thor P
Pol Merkur Lekarski; 2011 Dec; 31(186):348-52. PubMed ID: 22239004
[TBL] [Abstract][Full Text] [Related]
3. Spectral heart rate variability analysis in experimental obstructive and chemical overactive bladder models.
Dobrek L; Skowron B; Baranowska A; Thor PJ
Adv Clin Exp Med; 2013; 22(3):337-46. PubMed ID: 23828674
[TBL] [Abstract][Full Text] [Related]
4. Influence of the novel antidepressant and melatonin agonist/serotonin2C receptor antagonist, agomelatine, on the rat sleep-wake cycle architecture.
Descamps A; Rousset C; Millan MJ; Spedding M; Delagrange P; Cespuglio R
Psychopharmacology (Berl); 2009 Jul; 205(1):93-106. PubMed ID: 19370342
[TBL] [Abstract][Full Text] [Related]
5. Heart rate variability in overactive bladder experimental model.
Dobrek L; Thor P
Arch Med Sci; 2013 Oct; 9(5):930-5. PubMed ID: 24273581
[TBL] [Abstract][Full Text] [Related]
6. Urodynamic effects of the bladder C-fiber afferent activity modulation in chronic model of overactive bladder in rats.
Juszczak K; Ziomber A; Wyczolkowski M; Thor PJ
J Physiol Pharmacol; 2009 Dec; 60(4):85-91. PubMed ID: 20065501
[TBL] [Abstract][Full Text] [Related]
7. The ameliorating effect of exogenous melatonin on urinary bladder function in hyperosmolar bladder overactivity and its influence on the autonomic nervous system activity.
Juszczak K; Ziomber A; Machowska A; Furgała A; Dobrek Ł; Wyczółkowski M; Thor PJ
Acta Medica (Hradec Kralove); 2011; 54(2):63-8. PubMed ID: 21842719
[TBL] [Abstract][Full Text] [Related]
8. Expression of E-series prostaglandin (EP) receptors and urodynamic effects of an EP4 receptor antagonist on cyclophosphamide-induced overactive bladder in rats.
Chuang YC; Yoshimura N; Huang CC; Wu M; Tyagi P; Chancellor MB
BJU Int; 2010 Dec; 106(11):1782-7. PubMed ID: 20346049
[TBL] [Abstract][Full Text] [Related]
9. Urodynamic investigation of cyclophosphamide-induced overactive bladder in conscious rats.
Pan F; Liu D; Han XM; Li WC; Pang ZL; Li B; Zhang XP; Xiao YJ; Zeng FQ
Chin Med J (Engl); 2012 Jan; 125(2):321-5. PubMed ID: 22340567
[TBL] [Abstract][Full Text] [Related]
10. Blockade of stress-induced increase of glutamate release in the rat prefrontal/frontal cortex by agomelatine involves synergy between melatonergic and 5-HT2C receptor-dependent pathways.
Tardito D; Milanese M; Bonifacino T; Musazzi L; Grilli M; Mallei A; Mocaer E; Gabriel-Gracia C; Racagni G; Popoli M; Bonanno G
BMC Neurosci; 2010 Jun; 11():68. PubMed ID: 20525261
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms and urodynamic effects of a potent and selective EP4 receptor antagonist, MF191, on cyclophosphamide and prostaglandin E2-induced bladder overactivity in rats.
Chuang YC; Tyagi P; Huang CC; Chancellor MB; Yoshimura N
BJU Int; 2012 Nov; 110(10):1558-64. PubMed ID: 22452546
[TBL] [Abstract][Full Text] [Related]
12. Hyperosmolarity alters micturition: a comparison of urinary bladder motor activity in hyperosmolar and cyclophosphamide-induced models of overactive bladder.
Juszczak K; Ziomber A; Wyczółkowski M; Thor PJ
Can J Physiol Pharmacol; 2010 Sep; 88(9):899-906. PubMed ID: 20921976
[TBL] [Abstract][Full Text] [Related]
13. Agomelatine(S 20098) antagonizes the penile erections induced by the stimulation of 5-HT2C receptors in Wistar rats.
Chagraoui A; Protais P; Filloux T; Mocaër E
Psychopharmacology (Berl); 2003 Oct; 170(1):17-22. PubMed ID: 12904965
[TBL] [Abstract][Full Text] [Related]
14. The influence of piroxicam, a non-selective cyclooxygenase inhibitor, on autonomic nervous system activity in experimental cyclophosphamide-induced hemorrhagic cystitis and bladder outlet obstruction in rats.
Dobrek Ł; Baranowska A; Skowron B; Thor PJ
Acta Pol Pharm; 2014; 71(3):497-507. PubMed ID: 25265830
[TBL] [Abstract][Full Text] [Related]
15. [Development of a new antidepressant : agomelatine].
Mocaër E; Delalleau B; Boyer PA; de Bodinat C
Med Sci (Paris); 2005 Oct; 21(10):888-93. PubMed ID: 16197911
[TBL] [Abstract][Full Text] [Related]
16. Synergistic mechanisms in the modulation of the neurotrophin BDNF in the rat prefrontal cortex following acute agomelatine administration.
Molteni R; Calabrese F; Pisoni S; Gabriel C; Mocaer E; Racagni G; Riva MA
World J Biol Psychiatry; 2010 Mar; 11(2):148-53. PubMed ID: 20109111
[TBL] [Abstract][Full Text] [Related]
17. Maternal melatonin or agomelatine therapy prevents programmed hypertension in male offspring of mother exposed to continuous light.
Tain YL; Lin YJ; Chan JYH; Lee CT; Hsu CN
Biol Reprod; 2017 Oct; 97(4):636-643. PubMed ID: 29025027
[TBL] [Abstract][Full Text] [Related]
18. Effect of agomelatine in the chronic mild stress model of depression in the rat.
Papp M; Gruca P; Boyer PA; Mocaër E
Neuropsychopharmacology; 2003 Apr; 28(4):694-703. PubMed ID: 12655314
[TBL] [Abstract][Full Text] [Related]
19. Preclinical evaluation of the reinforcing and discriminative stimulus effects of agomelatine (S-20098), a melatonin agonist.
Wiley JL; Dance ME; Balster RL
Psychopharmacology (Berl); 1998 Dec; 140(4):503-9. PubMed ID: 9888627
[TBL] [Abstract][Full Text] [Related]
20. Effect of agomelatine and its interaction with the daily corticosterone rhythm on progenitor cell proliferation in the dentate gyrus of the adult rat.
AlAhmed S; Herbert J
Neuropharmacology; 2010 Nov; 59(6):375-9. PubMed ID: 20685215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
